|
|
|
|
|
Eptifibatide Acetate |
|
pharmaceutical |
|
148031-34-9 |
|
Molecular Formula C35H49N11O9S2 Molecular Weight 831.96 1 Appearence White to Off-white powder Comforms 2 Specific Optical Rotation -75.0¢¦-95.0( c=1%,HAc) -84.86¡Æ 3 Water Content(Karl Fischer) ¡Â8.0% 2.53% 4 Amino Acid Composition ¡¾20% Conforms 5 Acetate Conten(By HPLC) ¡Â15.0% 2.2% 6 Peptide Purity(By HPLC) ¡Ã98.0% by area integration 99.9% 7 Related Substance(By HPLC) Total Impurities(%)¡Â2.0% Largest Single Impurity(%)¡Â1.0% 0.1% 0.1% 8 MeCN ¡Â0.041% 0.01% 9 Bacterial Endotoxins ¡Â5EU/mg Conforms 10 Assay 95.0¢¦103.0%(By Anhydrous,Acetic Acid-free) 98.5%
|
|
USP31/EP6
|
|
Molecular Formula C35H49N11O9S2 Molecular Weight 831.96 1 Appearence White to Off-white powder Comforms 2 Specific Optical Rotation -75.0¢¦-95.0( c=1%,HAc) -84.86¡Æ 3 Water Content(Karl Fischer) ¡Â8.0% 2.53% 4 Amino Acid Composition ¡¾20% Conforms 5 Acetate Conten(By HPLC) ¡Â15.0% 2.2% 6 Peptide Purity(By HPLC) ¡Ã98.0% by area integration 99.9% 7 Related Substance(By HPLC) Total Impurities(%)¡Â2.0% Largest Single Impurity(%)¡Â1.0% 0.1% 0.1% 8 MeCN ¡Â0.041% 0.01% 9 Bacterial Endotoxins ¡Â5EU/mg Conforms 10 Assay 95.0¢¦103.0%(By Anhydrous,Acetic Acid-free) 98.5%
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|